Used as a chiral intermediate in the synthesis of pharmaceuticals, particularly in the development of central nervous system (CNS) agents. Its trifluoromethyl and bromo-substituted aryl groups make it valuable in medicinal chemistry for enhancing metabolic stability and binding affinity. Commonly employed in asymmetric synthesis to introduce chirality in active pharmaceutical ingredients (APIs). Also utilized in the preparation of fluorinated analogs of bioactive molecules, where the fluorine atoms improve lipophilicity and bioavailability.